Richie Khanna

2.2k total citations
39 papers, 1.7k citations indexed

About

Richie Khanna is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Richie Khanna has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 12 papers in Molecular Biology and 10 papers in Cell Biology. Recurrent topics in Richie Khanna's work include Lysosomal Storage Disorders Research (21 papers), Cellular transport and secretion (9 papers) and Trypanosoma species research and implications (8 papers). Richie Khanna is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Cellular transport and secretion (9 papers) and Trypanosoma species research and implications (8 papers). Richie Khanna collaborates with scholars based in United States, India and Germany. Richie Khanna's co-authors include Kenneth J. Valenzano, Brandon A. Wustman, Elfrida R. Benjamin, Megerditch Kiledjian, Allan Powe, David J. Lockhart, Robert E. Boyd, Gary Lee, Yi Lun and John J. Flanagan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Neuroscience.

In The Last Decade

Richie Khanna

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richie Khanna United States 22 1.1k 799 495 478 380 39 1.7k
Adele Cooney United States 19 828 0.8× 976 1.2× 240 0.5× 479 1.0× 158 0.4× 25 2.1k
Eduard Orviský United States 16 732 0.7× 527 0.7× 229 0.5× 577 1.2× 132 0.3× 35 1.2k
Tama Dinur Israel 22 859 0.8× 643 0.8× 308 0.6× 416 0.9× 156 0.4× 64 1.3k
Ryan D. Martinus New Zealand 18 869 0.8× 1.0k 1.3× 82 0.2× 447 0.9× 189 0.5× 28 1.6k
Mark Rosenbach United States 17 233 0.2× 1.9k 2.4× 373 0.8× 458 1.0× 105 0.3× 23 2.5k
Alexander V. Skurat United States 23 381 0.4× 798 1.0× 189 0.4× 216 0.5× 82 0.2× 37 1.5k
Yunxiang Zhu United States 22 482 0.4× 1.0k 1.3× 131 0.3× 578 1.2× 159 0.4× 43 1.7k
Daniel Canals United States 27 426 0.4× 1.6k 2.0× 169 0.3× 438 0.9× 191 0.5× 48 2.0k
Ningguo Gao United States 20 182 0.2× 1.0k 1.3× 211 0.4× 458 1.0× 230 0.6× 30 1.5k
Clara W. Hall United States 18 689 0.6× 697 0.9× 316 0.6× 373 0.8× 199 0.5× 23 1.5k

Countries citing papers authored by Richie Khanna

Since Specialization
Citations

This map shows the geographic impact of Richie Khanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richie Khanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richie Khanna more than expected).

Fields of papers citing papers by Richie Khanna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richie Khanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richie Khanna. The network helps show where Richie Khanna may publish in the future.

Co-authorship network of co-authors of Richie Khanna

This figure shows the co-authorship network connecting the top 25 collaborators of Richie Khanna. A scholar is included among the top collaborators of Richie Khanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richie Khanna. Richie Khanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
De, Bishnu P., Jonathan B. Rosenberg, Stephen M. Kaminsky, et al.. (2024). Expression and processing of mature human frataxin after gene therapy in mice. Scientific Reports. 14(1). 8391–8391. 2 indexed citations
3.
Günaydın, Caner, Dolan Sondhi, Philip L. Leopold, et al.. (2024). AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer’s disease mice. Molecular Therapy. 32(12). 4303–4318. 7 indexed citations
4.
De, Bishnu P., Jonathan B. Rosenberg, Stephen M. Kaminsky, et al.. (2023). Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease. Human Gene Therapy. 34(17-18). 905–916. 5 indexed citations
5.
Miller, Michelle S., Lynn Kamen, Roman Wernyj, et al.. (2023). Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays. Pharmaceutical Research. 40(10). 2383–2397. 4 indexed citations
6.
Khanna, Richie, et al.. (2019). Challenges in treating Pompe disease: an industry perspective. Annals of Translational Medicine. 7(13). 291–291. 46 indexed citations
7.
Hamler, Rick, Nastry Brignol, Sean W. Clark, et al.. (2017). Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease. Analytical Chemistry. 89(16). 8288–8295. 22 indexed citations
8.
Richter, Franziska, Sheila M. Fleming, Melanie B. Watson, et al.. (2014). A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy. Neurotherapeutics. 11(4). 840–856. 89 indexed citations
9.
Nayak, Sushrusha, Phillip A. Doerfler, Stacy Porvasnik, et al.. (2014). Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent. PLoS ONE. 9(6). e98336–e98336. 21 indexed citations
10.
11.
Khanna, Richie, Su Xu, Yi Lun, et al.. (2013). Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease. Molecular Genetics and Metabolism. 108(2). S53–S53. 1 indexed citations
12.
Khanna, Richie, John J. Flanagan, Jessie Feng, et al.. (2012). The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease. PLoS ONE. 7(7). e40776–e40776. 66 indexed citations
13.
Benjamin, Elfrida R., Richie Khanna, Adriane Schilling, et al.. (2012). Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice. Molecular Therapy. 20(4). 717–726. 71 indexed citations
14.
Lun, Yi, Anthony C. Stevens, Hadis Williams, et al.. (2012). Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide. Journal of Neuroscience. 32(15). 5223–5236. 75 indexed citations
15.
Valenzano, Kenneth J., Richie Khanna, Allan Powe, et al.. (2011). Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders. Assay and Drug Development Technologies. 9(3). 213–235. 127 indexed citations
16.
Khanna, Richie, Rebecca Soska, Yi Lun, et al.. (2009). The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease. Molecular Therapy. 18(1). 23–33. 107 indexed citations
17.
Lieberman, Raquel L., Brandon A. Wustman, Pedro E. Huertas, et al.. (2006). Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nature Chemical Biology. 3(2). 101–107. 191 indexed citations
18.
Khanna, Richie & Megerditch Kiledjian. (2004). Poly(A)‐binding‐protein‐mediated regulation of hDcp2 decapping in vitro. The EMBO Journal. 23(9). 1968–1976. 51 indexed citations
19.
Lal, Rup, et al.. (2000). Regulation and manipulation of the gene clusters encoding type-I PKSs. Trends in biotechnology. 18(6). 264–274. 29 indexed citations
20.
Tuteja, Dipika, Meenakshi Dua, Richie Khanna, et al.. (2000). The Importance of Homologous Recombination in the Generation of Large Deletions in Hybrid Plasmids in Amycolatopsis mediterranei. Plasmid. 43(1). 1–11. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adele Cooney Breakdown of academic impact, for papers by Eduard Orviský Breakdown of academic impact, for papers by Tama Dinur Breakdown of academic impact, for papers by Ryan D. Martinus Breakdown of academic impact, for papers by Mark Rosenbach Breakdown of academic impact, for papers by Alexander V. Skurat Breakdown of academic impact, for papers by Yunxiang Zhu Breakdown of academic impact, for papers by Daniel Canals Breakdown of academic impact, for papers by Ningguo Gao Breakdown of academic impact, for papers by Clara W. Hall
Rankless by CCL
2026